• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

• 페이스북 공유
• 트위터 공유
• 

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. Little data exists about how to get adhd medication without diagnosis long-term exposure to these drugs may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological disorders like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to consider the benefits of taking it against the possible dangers for the baby. Physicians don't have the information needed to make unequivocal recommendations but they can provide information regarding benefits and risks that can help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy were not at a greater risk of fetal malformations or structural birth defects. Researchers conducted a large population-based study of case-control to assess the risk of major structural birth defects in babies born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Clinical geneticists, pediatric cardiologists and other experts examined the cases to ensure that the classification was accurate and to reduce any bias.

However, the researchers' study had its limitations. In particular, they were unable to separate the effects of the medication from the disorder at hand. This makes it difficult for researchers to determine whether the small associations observed among the exposed groups were due to medication use or if they were affected by comorbidities. The researchers also did not study long-term outcomes for offspring.

The study did show that babies whose mothers had taken ADHD medications during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or taken off their medication prior to or during pregnancy. The reason for this was central nervous system disorders, and the higher risk of admission was not found to be influenced by the stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases didn't appear to be affected by the kind of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy could be offset by the higher benefit to both mother and child from continued treatment for the woman's disorder. Physicians should speak with their patients about this and try to help them develop coping skills that may reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

As more women than ever before are being diagnosed with ADHD and treated with medication, the dilemma of whether to continue or end treatment during pregnancy is one that more and more doctors have to face. These decisions are often taken without clear and authoritative evidence. Instead, doctors must take into account their own experience and experience, as well as the experiences of other physicians and the research on the subject.

In particular, the issue of possible risks to the baby can be tricky. The research on this issue is based on observations rather than controlled studies and many of the findings are conflicting. The majority of studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these issues by examining data on both live and deceased births.

Conclusion: While some studies have found a positive correlation between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show an unintended, or somewhat negative, impact. Therefore an accurate risk-benefit analysis must be conducted in every instance.

It isn't easy, but not impossible for women suffering from adhd medication online uk to stop taking their medication. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness and family conflict for these patients. Additionally, the loss of medication can affect the ability to complete work-related tasks and safely drive that are crucial aspects of a normal life for many people suffering from ADHD.

She suggests women who are uncertain about whether to keep or stop taking medication because of their pregnancy consider informing family members, friends and colleagues about the condition, its effects on daily functioning, and the advantages of continuing the current treatment plan. Educating them can also aid in ensuring that the woman feels supported as she struggles with her decision. Some medications can pass through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it is crucial to be aware that the medication may be transferred to her baby.

Risk of Birth Defects

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns over the impact that these medications could have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing information on this topic. With two massive data sets researchers were able look at more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to common adhd medications uk medications was associated with a slightly higher rate of specific heart defects, like ventriculo-septal defects (VSD).

The researchers behind the study found no association between early medication use and other congenital abnormalities, such as facial clefting or club foot. The results are in the same vein as previous studies that have shown an insignificant, but small increase in cardiac malformations for women who started taking ADHD medication prior to the time of pregnancy. The risk was higher in the later part of pregnancy, as many women begin to discontinue their medication.

Women who were taking ADHD medication in the first trimester were more likely to require a caesarean delivery and also have an insufficient Apgar after delivery, and had a baby that required help breathing when they were born. The authors of the study could not remove bias in selection since they limited the study to women with no other medical conditions that might have contributed to the findings.

Researchers hope that their study will inform physicians when they see pregnant women. They advise that while the discussion of the benefits and risks is important, the decision to stop or keep medication should be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, while stopping the medication is a possibility to think about, it isn't advised due to the high rate depression and mental health issues for women who are pregnant or recently gave birth. Further, research shows that women who stop taking their medications will have a difficult adjustment to life without them after the baby is born.

Nursing

It can be a challenge becoming a mother. Women suffering from ADHD are often faced with a number of difficulties when they must deal with their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to a new routine. As such, many women choose to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs are absorbed by breast milk in very small amounts, therefore the risk for breastfeeding infant is minimal. However, the rate of exposure to medications by the newborn may differ based on dosage, frequency it is administered, and the time of day the medication is administered. Additionally, individual medications enter the baby's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't fully known.

Due to the absence of research, some doctors might be tempted to stop taking stimulant medications during the pregnancy of a woman. This is a complicated decision for the patient, who must weigh the benefits of keeping her medication against the possible dangers to the fetus. Until more information is available, GPs should ask all pregnant patients about their history of ADHD and if they are taking or planning where to get prescribed adhd medication take medication during the perinatal period.

Numerous studies have demonstrated that women can continue taking their getting adhd Medication uk medication in a safe manner during pregnancy and while breast-feeding. As a result, more and more patients are choosing to do so, and after consulting with their doctor, they have found that the benefits of keeping their current medication far exceed any risk.

Women who suffer from ADHD who are planning to nurse should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be offered to help pregnant people with ADHD recognize their symptoms and the root cause and learn about treatments and to reinforce existing coping strategies. This should be a multidisciplinary approach together with obstetricians, GPs, and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, monitoring of indicators of deterioration, and, if necessary, adjustments to the medication regime.